Arcus Biosciences Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Arcus Biosciences, Inc. (RCUS)

24.13 +0.70 (+2.99%) USD | NYSE | May 26, 16:00

24.38 +0.25 (+1.04%) Pre-Market: 09:16

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for RCUS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Amgen, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade